Skip to main content
. 2022 Apr 7;13:847105. doi: 10.3389/fimmu.2022.847105

Table 1.

62 HBV epitopes and their HLA-A cross-restrictions validated by multiple approaches.

Epitope name Protein Epitope sequence HBV genotype Cons (%) Predicted HLA restriction ELISPOT positive Activating CD8+ T cell Reported HLA restriction Bioinformatics analysis Peptide competitive binding assay for HLA-A
Patient’s HLA Patient’s HLA Prime-affinity High affinity Inter affinity Low affinity No affinity
P2 HBsAg FLLTRILTI C/D ≥ 95 A0201, A0206 A0207 A0201/1136 A0201, A0205 A0206 (37) A0201 A0207 A0206 A1101
P6 HBsAg LLCLIFLLV A/B/C/D ≥ 95 A0201, A0101 A0201/1136 A0201/0207A0201/3001 A02 (38) A0207 A1101>A0101>A0201
P7 HBsAg WLSLLVPFV A/B/C/D ≥ 95 A0201, A0206 A0207, A0203 A0201/1136 A2402/2402 A1101/1101 A0201, A0202 A0206, A0203 A0207, A0205 (39) A0203 >A0201>A0206 A0207 A1101>A2402
P8 HBsAg GLSPTVWLSV A/B/C/D ≥ 95 A0201 A0201/1136 A0201/3001 A0201 (40) A0201 A1101
P13 HBsAg SMYPSCCCTK D ≥ 95 A1101, A1102 A0301 A0201/0206 A0201>A1101>A0301 A1101 >A0301>A1102 A0206
P14 HBsAg ASPISSIFSR C 80-95 A1101 A0206/1101 A1101 A1101 A0206
P19 HBsAg LYSILSPFL C/D 80-95 A2402 A2402/2402 A0201/1136 A0201/3201 A0201/0206 A2402 A2402 A0206>A0201>A1101
P20 HBsAg LFILLLCLI A/C/D ≥ 95 A2402 A2402/2402 A1101/1101 A2402 A1101>A2402
P38 HBsAg SPISSIFSR C 80-95 A0201, A1101 A0201/0201 A1101/3101 A0201>A1101 A1101>A3101>A0201
P39 HBsAg SAISSISSK B < 80 A1101 A1101/0203 A1101>A0203 A1101 A0203
P40 HBsAg QAGFFSLTK B < 80 A1101, A1102 A1101/3101 A1101/1101 A1101>A3101 A1101 A3101
P41 HBsAg QAGFFLLTR C/D ≥ 95 A1101, A1102 A1101/0201 A0201/2402 A1101>A1102 A1101>A1102>A0201
P51 HBsAg VWLSVIWMMW A/B/C/D ≥ 95 A2402 A0201/0207 A1101/1102 A2402>A0201>A0207 A2402 A0207 A0201
P71 HBsAg MMWFWGPSL B 80-95 A0207, A0301 A0101 A2402/2402 A2402/24109 A2402>A0207>A0301 A0207>A2402 A0301 A0101
P72 HBsAg MMWYWGPSL A/C/D ≥ 95 A0207, A1102 A0301, A0101 A0201/0201 A2402/0207 A0201>A0207>A2402 A0201>A2402>A0207 A0301 A0101>A1101>A1102
P77 HBsAg CPGYRWMCLR A/B/C/D ≥ 95 A3303 A0201/0201 A0201/3303 A3303 A3303>A0201
P78 HBsAg FLWEWASVR C ≥ 95 A3303 A0201/2402 A0201>A3303>A2402 A0201> A3303 A2402
P95 HBsAg LLDYQGMLPV A/B/C/D ≥ 95 A0203 A2402/2402 A2402/2402 A3303/3001 A02 (38) A0203>A2402 A0203 A2402
P103 HBsAg LQAGFFSLTK B < 80 A1102 A2402/0207 A0207>A2402>A1102 A1101 A0207 A1102>A2402
P108 HBsAg MMWYWGPSLY A/C/D ≥ 95 A0301, A0101 A1102 A2402/0207A2402/0207 A03 (37) A2402>A0301>A0207 A0207>A1101>A0301 A0101>A2402>A1102
P1 HBeAg FLPSDFFPSV A/D ≥ 95 A0201, A0203 A0207, A0206 A0201/1136 A2402/3303 A1101/1101 A0201, A0203 A0206, A0207 (30) A0201>A0206>A0203 A0207 A2402>A3303>A1101
P4 HBeAg LVSFGVWIR A/B/C/D ≥ 95 A1101, A1102 A1101/0206 A0201/0206 A33 (41) A1101>A3303 A0206>A0201>A1102
P11 HBeAg YLVSFGVWI A/B/C/D ≥ 95 A0201, A0203 A0201/1136 A2402/1101 A2402/3303 A2402/0203 A0203/0203A1101/0301 A0201 (42) A0203>A0201 A2402 A1101> A3303
P22 HBeAg SYVNTNMGL D 80-95 A2402 A2402/2402 A0206/1101 A0201 (32) A2402 A1101>A0201> A0206
P23 HBeAg EYLVSFGVW A/B/C/D ≥ 95 A2402 A1101/1101 A0201/3201 A0207/2402 A2402, A2407 A2301 (43) A2402 A0201>A1101
P31 HBeAg FLPSDFFPSI B/C ≥ 95 A0201, A0207 A0203 A0207/2402 A1101/2463 A1101/1101 A0201, A0207 (40) A0207>A0201>A1101 A0203>A0201>A2402 A0207 A1101
P32 HBeAg LLWFHISCL A/B/C/D ≥ 95 A0201 A0201/2402 A2402/1101A0207/0207 A0201 (42) A2402>A0201
P42 HBeAg STLPETTVVR A/B/C/D / A1101, A1102 A1101/0201 A1101/2463 A0207/3001 A1101/1102 A0201, A11 A6801 (37) A1101>A0207 A1101 A0207 A1102>A0201>A3001
P52 HBeAg WFHISCLTF A/B/C/D ≥ 95 A2402 A2402/0207 A0201/0207 A2402>A0207>A0201 A2402 A0207 A0201
P53 HBeAg SYVNVNMGL A/B/C 80-95 A2402 A2402/0207 A0207/0206A0201/2402A0206/1101 A2402>A0207 A2402 A0207
P67 HBeAg FLPSDFFPS A/B/C/D ≥ 95 A0206, A0201 A0207, A0203 A2402/2601 A2402/3303 A3303/3001 A02 (44) A0206>A0201>A0203 A0207 A2402>A3303
P74 HBeAg ILCWGELMNL B/C ≥ 95 A0207 A2402/0207 A2402/3315 A0207>A2402 A0201 A0207 A2402>A3303
P88 HBeAg ASRELVVSY B/C 80-95 A3001 A0201/0201 A0206/0206 A0101/0206 A0101/0206 A0201/2601 A0201/0206 A0201>A3001>A0206 A3001 A0201 A0101>A0206
P118 HBeAg ETVLEYLVSV C ≥ 95 A2601 A1101/2402 A1101/2402 A0203/3001 A0201/1101 A0201/0207 A2601>A1101>A0201 A0207>A3001 A1101>A0203>A0201>A2402
P66 HBeAg MQLFHLCLI A/B/C/D / A0206 A0201/0201 A3303/3001 A0201 (16) A0201 A0206
P96 HBeAg ILSTLPETTV A/B/C/D / A0203 A0201/0201 A02 (45) A0201>A0203 A0203 A0201
P111 HBeAg LLDTASALY A/B/D ≥ 95 A0101, A1102 A2402/2402 A2402/0207 A1101/1101 A0101>A1102 A0101 A0207 A1101>A0201>A2402>A1102
P10 HBpol FLLSLGIHL A/B/C/D ≥ 95 A0201, A0206 A0207 A0201/1136 A0201/0201 A0206/0206 A2402/1101 A2402/3303 A1101/1101 A0201, A0206 A0202 (37) A0201>A3303 A0207>A0206 A2402>A1101
P15 HBpol KVTKYLPLDK D < 80 A1101 A0206/1101 A1101 A1101 A0206
P16 HBpol PTYKAFLCK C/D < 80 A1101, A1102 A1101/0206 A0203/1101 A1101>A0206 A1101 A1102>A0206
P24 HBpol KYTSFPWLL A/B/C/D ≥ 95 A2402 A0201/0206 A2301, A2402 (46) A2402 A0201>A0206
P25 HBpol FYPKVTKYL D < 80 A2402 A1101/1101 A2402>A1101 A2402 A1101
P33 HBpol KLIGTHNSV B < 80 A0201, A0203 A0201/0201 A1101/0203 A0201>A0203>A1101 A0201 A0203 A1101
P34 HBpol KLIGTDNSV A/C 80-95 A0201, A0203 A0201/2402 A1101/1101A3303/2601 A0201>A0203 A0201 A0203 A2402
P55 HBpol LYSSTVPCF B < 80 A2402 A0201/3303 A0201/2402 A2402>A3303>A0201 A2402 A0201>A3303
P56 HBpol LYSSTVPVF C ≥ 95 A2402 A0201/0207 A2402>A0207 A2402 A0207 A0201
P76 HBpol FLLAQFTSA A/B/C/D ≥ 95 A0207, A0203 A0207/1101 A0203>A0207 A0207>A0203 A1101
P89 HBpol RSRSGAKLI B/C 80-95 A3001 A0201/0201 A0101/0206 A0206/0206 A0201/3001 A0201>A0206>A3001 A3001 A0201 A0206>A0101
P90 HBpol RSRSGANIL C/D ≥ 95 A3001 A0201/0201 A0201>A3001 A3001 A0201
P98 HBpol LLAQFTSAI A/B/C/D ≥ 95 A0203 A0203/0301 A0203/0201 A0201 (42) A0203 A0203 A0201
P106 HBpol TLWKAGILYK A/B/C/D ≥ 95 A1102, A0301 A2402/2402 A2402/2402 A2402/2402 A03 (47) A0301>A2402>A1102 A0301 A1101 A1102>A2402
P119 HBpol HTAELLAACF A/B/C/D ≥ 95 A2601 A2402/2402 A2402>A2601 A2402
P12 HBx CLFKDWEEL D ≥ 95 A0201 A0201/1136 A0201 (48) A0201 A1101
P17 HBx TVNAHQILPK A/D < 80 A1101, A1102 A0301 A1101/3001 A3303/2601 A1101>A3001 A1101 A3001
P18 HBx STTDLEAYFK A/B/C/D ≥ 95 A1101 A0201/0206 A0206/1101 A0201>A1101>A0206 A1101 A0206>A0201
P26 HBx VCAPAPCNF D 80-95 A2402 A0206/1101 A2402/2402 A1101/3303 A2402 A1101> A2402>A0206
P36 HBx VLGGCRHKL A/B/C/D ≥ 95 A0201 A1101/3101 A0201 (49) A0201 A1101>A3101
P47 HBx TVNAHGNLPK B < 80 A1101, A1102 A0301 A1101/0201 A0201>A1101>A0301 A1101>A0301 A1102 A0201
P48 HBx TVNAHQVLPK C < 80 A1101, A1102 A0301 A1101/0201 A1101/1102 A1101 A1101>A0301 A1102 A0201
P63 HBx KVFVLGGCR A/B/C/D < 80 A3101, A0301 A2402/2402 A1101/1101A3303/2601 A2402>A3101 A3101 A2402
P93 HBx RLKVFVLGG A/B/C/D < 80 A3001 A2402/2402 A2402>A3001 A3001>A2402
P100 HBx HLSLRGLPV A/B/C/D ≥ 95 A0203 A2402/2402 A2402/2402 A2402/2402 A1101/1101 A0201 (49) A0203 A2402

ELISPOT positive, the epitope peptide induced positive T cell response in the ex vivo IFN-γ ELISPOT assay with the indicated patient’s PBMCs. Activating CD8+ T cell, the epitope peptide induced positive CD8+ T cell response in the in vitro cocultures with the indicated patient’ PBMCs. Cons (%), conservation (%).